Cargando…
Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China
It has been reported that IDH1 (IDH1R132) mutation was a frequent genomic alteration in grade II and grade III glial tumors but rare in primary glioblastoma (pGBM). To elucidate the frequency of IDH1 mutation and its clinical significance in Chinese patients with pGBM, one hundred eighteen pGBMs wer...
Autores principales: | Yan, Wei, Zhang, Wei, You, Gan, Bao, Zhaoshi, Wang, Yongzhi, Liu, Yanwei, Kang, Chunsheng, You, Yongping, Wang, Lei, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264567/ https://www.ncbi.nlm.nih.gov/pubmed/22291938 http://dx.doi.org/10.1371/journal.pone.0030339 |
Ejemplares similares
-
Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type
por: Wang, Zheng, et al.
Publicado: (2013) -
MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
por: Li, Guanzhang, et al.
Publicado: (2018) -
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
por: Yang, Pei, et al.
Publicado: (2015) -
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018) -
IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma
por: Zeng, Ailiang, et al.
Publicado: (2015)